Reshma Kewalramani |
CEO & President, Director |
$46.1M |
-$33.7M |
-42.2% |
Jul 30, 2024 |
Bruce I. Sachs |
Director |
$28M |
-$10.2M |
-26.7% |
Aug 1, 2024 |
Amit Sachdev |
EVP Chief Patient & Ext Af Off |
$26.8M |
-$5.8M |
-17.8% |
Jun 5, 2024 |
Ourania Tatsis |
EVP, Chief Reg. & Quality Off. |
$22.6M |
-$3.67M |
-14% |
Jun 3, 2024 |
Charles F. Wagner Jr |
EVP & Chief Financial Officer |
$21.7M |
-$5.24M |
-19.5% |
Jun 3, 2024 |
Stuart A. Arbuckle |
Evp, Coo |
$21.5M |
-$11M |
-33.8% |
May 15, 2024 |
Bastiano Sanna |
EVP, Cell & Genetic Therapies |
$13.4M |
|
|
May 5, 2023 |
David Altshuler |
EVP, Chief Scientific Officer |
$11.1M |
-$6.11M |
-35.4% |
May 15, 2024 |
Carmen Bozic |
EVP and CMO |
$11.1M |
-$14.7M |
-57% |
Aug 7, 2024 |
Jonathan Biller |
EVP and Chief Legal Officer |
$7.66M |
-$939K |
-10.9% |
Feb 9, 2024 |
Edward Morrow Atkinson III |
EVP, Chief Technical Ops. Off. |
$7.63M |
-$5.09M |
-40% |
Jun 11, 2024 |
Jeffrey M. Leiden |
Executive Chairman, Director |
$5.21M |
-$20.1M |
-79.4% |
Aug 30, 2024 |
Joy Liu |
SVP, General Counsel |
$4.03M |
|
|
Aug 15, 2022 |
Diana Mckenzie |
Director |
$3.48M |
|
|
May 1, 2024 |
Kristen Ambrose |
SVP & Chief Accounting Officer |
$3.14M |
-$1.05M |
-25.1% |
Apr 1, 2024 |
Terrence C. Kearney |
Director |
$3.14M |
|
|
May 1, 2024 |
Margaret G. Mcglynn |
Director |
$2.95M |
|
|
May 1, 2023 |
Lloyd Carney |
Director |
$2.55M |
|
|
May 1, 2024 |
Sangeeta N. Bhatia |
Director |
$2.22M |
-$1.29M |
-36.8% |
Aug 30, 2024 |
Suketu Upadhyay |
Director |
$1.6M |
|
|
May 1, 2024 |
Yuchun Lee |
Director |
$1.23M |
|
|
May 1, 2023 |
Michel Lagarde |
Director |
$875K |
|
|
May 1, 2024 |
Nancy Thornberry |
Director |
$860K |
|
|
May 1, 2024 |
Alan M. Garber |
Director |
$401K |
|
|
May 1, 2024 |
Jennifer Schneider |
Director |
$372K |
|
|
May 15, 2024 |